trial summary · NCT07818564
Pilot Study on the Effects of Psilocybin on Belief Updating and Insight Formation
Trial record from the TrialBase DB dataset, status RECRUITING, condition Phase I, sponsored by Brown University. Facts below are exported values from the current release, not inferred or edited prose.
Summary
The brief summary is the registry's published description, capped for length. Field definitions, types, and provenance rules are in the data dictionary.
The primary aim of this phase I mechanistic pilot study is to evaluate the effects of psilocybin on aspects of cognition in healthy adult volunteers. Up to 24 participants will receive a single dose of either psilocybin or inert placebo, and they will be asked to complete several computer-based behavioral tasks measuring features of learning, belief updating, and abstraction. Participants will also complete measures of subjective experience and expectancy, as well as semi-structured interviews at follow up, to assess whether experience correlates with behavior. This is a Voluntary Submission.
Source record: https://clinicaltrials.gov/study/NCT07818564
Facts
| registry id | NCT07818564 |
|---|---|
| primary registry | clinicaltrials-gov |
| recruitment status | RECRUITING |
| phase | PHASE1 |
| study type | INTERVENTIONAL |
| lead condition | Phase I |
| sponsor | Brown University |
| sponsor class | OTHER |
| enrollment | 24 |
| start date | 2026-11 |
| primary completion | 2027-11 |
| completion | 2027-11 |
| results posted | not reported |
Conditions
- Phase I
Interventions
- Psilocybin (Usona Institute)
- Inactive Placebo (Usona Institute)
Countries
- United States
Intervention types: DRUG
Work with this record
- Field definitions
Types, scope, and provenance rules for every exported field.
- REST API
Query the same gate-backed records programmatically.
- Evaluation sample
Download a bounded slice before buying.
- $29 API Pass
Seven days of REST and MCP access; credited toward the licence.